Objective This article reviews the current results of various locoregional therapies for
hepatocellular carcinoma (HCC), with special reference to the implications for surgeons …

BACKGROUND: Transcatheter arterial (chemo) embolization (TACE), cryoablation (CA) and
percutaneous ethanol injection (PEI) were the first regional and local ablative techniques …

A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for
hepatocellular carcinoma with cirrhosis - PMC Back to Top Skip to main content NIH NLM Logo …

Hepatocellular carcinoma (HCC) is one of the most common tumors globally, with varying
prevalence based on endemic risk factors. In high-risk populations, including those with …

Background: This paper reports a 7‐year experience of cryoablation for colorectal and non‐
colorectal liver metastases. Methods: A retrospective review was undertaken of patients …

Background Most patients with liver tumours are not suitable for surgery but interstitial
ablative techniques may control disease progression and improve survival rates. Methods A …

Management of hepatocellular carcinoma (HCC) is a challenging task because of the
intricate underlying liver disease and the occult nature of the disease. Moreover, changing …

While surgical resection and tumor ablation are the preferred therapies for hepatocellular
carcinoma (HCC), these are available or appropriate in only a minority of patients. This …

Although morbidity following cryotherapy is usually minor, a syndrome of multiorgan failure
and disseminated intravascular coagulation (DIC) has been described and referred to as the …

Most cirrhotic patients with hepatocellular carcinoma (HCC) are not candidates for resection.
Transarterial chemoembolization (TACE) may ablate a significant portion of the tumor but …